Abortion Pill Access in Flux: Providers Adapt After Fifth Circuit and Supreme Court Rulings
Following a Fifth Circuit Court of Appeals decision restricting nationwide access to the abortion pill mifepristone via telehealth, providers scramble...
Following a Fifth Circuit Court of Appeals decision restricting nationwide access to the abortion pill mifepristone via telehealth, providers scramble...
The U.S. Supreme Court has extended the deadline for the FDA to respond to a legal challenge regarding mifepristone access. The decision comes as part...
Justice Samuel Alito extended an administrative stay halting a Fifth Circuit Court order that blocked mifepristone prescriptions via telemedicine. The...
The U.S. Supreme Court has temporarily extended access to mifepristone, a widely used abortion pill, until at least Thursday. Justice Samuel Alito's o...
The U.S. Supreme Court temporarily paused a Fifth Circuit ruling blocking telemedicine abortion access, but the fight over mifepristone threatens to r...
In April 2025, reproductive rights activists protested outside the Supreme Court, highlighting the flawed arguments against the abortion pill mifepris...
The U.S. Supreme Court has temporarily reinstated broad access to the abortion pill mifepristone, allowing distribution via telehealth, mail, and phar...
A federal court has blocked the mailing of mifepristone, a key abortion medication, raising concerns over access to reproductive healthcare. The decis...
A conservative federal appeals court reinstated in-person requirements for mifepristone, blocking telemedicine abortion providers and disrupting acces...
A Fifth Circuit panel has granted Louisiana a stay against the FDA’s 2023 telemedicine approval for mifepristone, requiring in-person evaluations befo...